Real-World Austrian Data Show Limits of Chemotherapy in High-Risk DLBCL Standard frontline and salvage chemotherapy provide suboptimal disease control in high-risk DLBCL, particularly after early treatment failure.

Standard #Chemotherapy-based approaches for diffuse large B-cell lymphoma (#DLBCL) produced acceptable outcomes in lower-risk patients but consistently poor results in high-risk disease and after frontline failure.

Read more: https://bit.ly/4rM6Slv

#RareDisease #DiffuseLargeBCellLymphoma

#Lymphopoiesiscont36 #NonHodgkinsLymphoma #BurkittLymphoma #FollicularLymphoma #MantleCellLymphoma #MarginalZoneLymphoma #DiffuseLargeBCellLymphoma #PrimaryCNSLymphoma #BCellLymphoma #LymphomaAwareness #Oncology #CancerEducation #MedicalNotes #Hematology #ChromosomalTranslocation #GeneticMutations #MedicalInfographic #Histopathology #MedicalLearning #MedStudent #Pathology

#Lymphopoiesiscont36
#NonHodgkinsLymphoma #BurkittLymphoma #FollicularLymphoma #MantleCellLymphoma #MarginalZoneLymphoma #DiffuseLargeBCellLymphoma #PrimaryCNSLymphoma #BCellLymphoma #LymphomaAwareness #Oncology #CancerEducation #MedicalNotes #Hematology #ChromosomalTranslocation #GeneticMutations

Michael Acceptor Pyrrolidone Derivatives and Their Activity against Diffuse Large B-cell Lymphoma

In this study, researchers synthesized 10 pyrrolidone-based compounds & identified compound 7 as a promising #therapeutic candidate, as it induced #Apoptosis and exhibited potent #antitumor activity against #DiffuseLargeBCellLymphoma. #medsky

Read: link.springer.com/article/10.1...